Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
Chip Davis Shares HDA’s 2024 Policy Priorities in Annual Chain Drug Review Column
With a presidential election on the horizon and policymakers working to develop solutions to challenges facing patients and providers, HDA’s President and CEO Chip Davis provided key insights into the association’s 2024 policy priorities in his annual column, “Health Care Outlook,” by Chain Drug Review.